Manisha Thapliyal | Bioinformatics | Best Researcher Award

Ms. Manisha Thapliyal | Bioinformatics | Best Researcher Award

Ms. Manisha Thapliyal, Patanjali Research Foundation, India.

Manisha Thapliyal is a dedicated scientist with six years of experience in biotechnology, bioinformatics, and computational drug design. She has led research teams, contributed to groundbreaking studies, and played a key role in developing novel therapeutic solutions. With expertise in plant genetic transformation, nanoparticle synthesis, and large-scale research projects, she is committed to advancing scientific innovation. Her passion for mentoring and organizing scientific events underscores her commitment to fostering future research talent.

Profile

Google Scholar

🌱 Early Academic Pursuits

Manisha Thapliyal’s journey into the world of scientific exploration began with a strong foundation in biotechnology and bioinformatics. Driven by an innate curiosity for life sciences, she pursued higher education with a focus on cutting-edge research methodologies. Her academic endeavors laid the groundwork for her specialization in computational drug design, plant genetic transformation, and nanotechnology. From her early years, she exhibited a passion for interdisciplinary studies, which later became a defining aspect of her professional career.

🧬 Professional Endeavors

With six years of experience in scientific research, Manisha Thapliyal has excelled in leading and managing research teams at the Patanjali Research Foundation in Haridwar. As a Scientist-B, she has guided Assistant Scientists in Computer-Aided Drug Designing (CADD), playing a pivotal role in developing potential therapeutic solutions. Her ability to seamlessly collaborate with bench scientists has ensured that computational strategies align with practical laboratory objectives. Through virtual screenings and molecular analyses, she has significantly contributed to identifying novel drug candidates with promising pharmacological potential.

 

🔬 Contributions and Research Focus

Manisha’s expertise extends across multiple domains, including plant genetic transformation studies, nanoparticle synthesis, and large-scale government-funded research projects. Her interdisciplinary approach bridges computational and experimental research, facilitating innovation in biotechnology. Her technical prowess in bioinformatics has enabled her to decode complex biological datasets, opening new avenues for scientific breakthroughs. Her research contributions are not limited to publications but extend to mentoring young scientists and fostering research-driven environments.

🏆 Accolades and Recognition

Recognized for her dedication and innovation in scientific research, Manisha has played a crucial role in several high-impact studies and book chapters. Her ability to integrate computational tools with experimental frameworks has earned her acclaim within the research community. She has been instrumental in organizing national and international conferences, workshops, and training programs, further solidifying her role as a thought leader in the field of biotechnology

🌍 Impact and Influence

Beyond her technical contributions, Manisha has been an active mentor, shaping the careers of aspiring researchers and young scientists. Her leadership in capacity-building initiatives has empowered the next generation of scientists to develop skills in drug discovery, genetic engineering, and bioinformatics. By fostering collaborative research environments, she has ensured that scientific advancements translate into meaningful healthcare and biotechnological solutions.

🔮 Legacy and Future Contributions

With an unwavering commitment to scientific excellence, Manisha Thapliyal envisions a future where biotechnology continues to drive innovation in medicine and environmental sustainability. Her focus remains on leveraging computational intelligence for precision drug discovery and sustainable biotechnological applications. As she advances in her career, she aims to expand her research horizon, bridging the gap between theoretical insights and real-world applications, ultimately contributing to the global scientific community.

Publication

  • SCREENING AND ISOLATION OF ANTIBACTERIAL PROTEINS/PEPTIDES FROM SEEDS OF MILLETS
    Authors: Anjali Bisht, Manisha Thapliyal
    Year: 2016

 

  • ISOLATION OF ANTIBACTERIAL PROTEIN/PEPTIDE FROM FICUS GLOMERATA LEAF
    Authors: Manisha Thapliyal, Anjali Bisht
    Year: 2016

 

  • Current Status of Indian Agriculture: Problems, Challenges and Solution
    Authors: Acharya Balkrishna, Manisha Phour
    Year: 2021

 

  • Role of AP2/EREBP Transcription Factor Family in Environmental Stress Tolerance
    Authors: Anjali Pande, Saurabh C Saxena, Manisha Thapliyal, Sudhir K Guru, Atul Kumar
    Year: 2018

 

  • Unraveling the therapeutic potential of Senna singueana phytochemicals to attenuate pancreatic cancer using protein–protein interactions, molecular docking, and …
    Authors: Acharya Balkrishna, D Sharma, M Thapliyal, V Arya, A Dabas
    Year: 2023

 

  • Isolation and Identification of α- Amylase activity Inhibiting compounds from Bryophyllum Pinnatum
    Authors: S R Kumar, M Thapliyal, A Singh
    Year: 2016

 

🏁 Conclusion

Manisha Thapliyal stands as a beacon of inspiration in the ever-evolving field of biotechnology. Her relentless pursuit of scientific excellence, coupled with her leadership in research and mentorship, has positioned her as a key contributor to scientific progress. Through her continued efforts in biotechnology and bioinformatics, she is set to make lasting contributions that will shape the future of drug discovery and sustainable scientific solutions.

 

Shahar Shelly | Epidemiology | Best Researcher Award

Dr. Shahar Shelly | Epidemiology | Best Researcher Award

Dr. Shahar Shelly,  Rambam Medical Center, Israel.

Dr. Shahar Shelly, MD, is a globally recognized neurologist and researcher specializing in neuroimmunology and neuromuscular disorders. With academic roles across Rambam Medical Center, Technion Institute, and the Mayo Clinic, Dr. Shelly has driven advancements in clinical diagnostics, treatment strategies, and disease understanding.

 

profile

Scholor

🎓 Education

University Medical School of Hungary, Debrecen – Summa Cum Laude (01/2005–01/2012). Shamir Medical Center, Zerifin, Israel – Internship (Cum Laude) (01/2012–01/2013). Sheba Medical Center – Residency, Neurology Department (01/2013–01/2017). Mayo Clinic, Rochester, MN – Neuroimmunology Fellowship (04/2018–07/2019). Neuromuscular Disorders, Muscle Fellowship – Mayo Clinic (07/2019–07/2020) Neuromuscular Disorders, Nerve Fellowship – Mayo Clinic (07/2020–07/2021).

📜 Certifications

Israeli Neurology Board Certification (2018). Educational Commission for Foreign Medical Graduates (ECFMG) (2018). Mayo Clinic Quality Fellow Certification (2019). Medical Genetics Certificate – Recanti Genetic Institute (2015). Advanced Electrophysiology Certification – Board-Licensed Electromyography (2019).

🏆 Honors & Awards

Summa Cum Laude – University Medical School of Hungary.  Cum Laude – Hassaf Harofeh Medical Center Internship.Israel Medical Association Fellowship Award (2017). Best Abstract Award – American Academy of Neurology (2019).

🔬 Patents & Innovations

Digital Drug Amplifier – Combines digital therapeutics with pharmaceuticals (FDA-approved). IMNM Muscle Disease Screening Software – Released for public use in the USA (2020).

🌐 Professional Memberships

American Neurological Association.Israeli Neuromuscular Society.American Association of Neuromuscular & Electrodiagnostic Medicine

📚 Publications

  • Prolactin and autoimmunity
    Authors: S Shelly, M Boaz, H Orbach
    Year: 2012

 

  • Autonomic dysfunction following COVID-19 infection: an early experience
    Authors: K Shouman, G Vanichkachorn, WP Cheshire, MD Suarez, S Shelly, et al.
    Year: 2021

 

  • Thymoma and autoimmunity
    Authors: S Shelly, N Agmon-Levin, A Altman, Y Shoenfeld
    Year: 2011

 

  • Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy
    Authors: S Shelly, JD Triplett, MV Pinto, M Milone, FE Diehn, A Zekeridou, et al.
    Year: 2020

 

  • Epidemiology and natural history of inclusion body myositis: a 40-year population-based study
    Authors: S Shelly, MM Mielke, J Mandrekar, M Milone, FC Ernste, E Naddaf, et al.
    Year: 2021

 

  • Survival and associated comorbidities in inclusion body myositis
    Authors: E Naddaf, S Shelly, J Mandrekar, AM Chamberlain, EM Hoffman, et al.
    Year: 2022

 

  • Small fiber neuropathy incidence, prevalence, longitudinal impairments, and disability
    Authors: SA Johnson, K Shouman, S Shelly, P Sandroni, SE Berini, PJB Dyck, et al.
    Year: 2021

 

  • Neurochondrin neurological autoimmunity
    Authors: S Shelly, TJ Kryzer, L Komorowski, R Miske, MD Anderson, EP Flanagan, et al.
    Year: 2019

 

  • Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study
    Authors: S Shelly, SL Zaltsman, O Ben-Gal, A Dayan, I Ganmore, C Shemesh, et al.
    Year: 2021

 

  • Neurofascin-155 immunoglobulin subtypes: clinicopathologic associations and neurologic outcomes
    Authors: S Shelly, CJ Klein, PJB Dyck, P Paul, ML Mauermann, SE Berini, B Howe, et al.
    Year: 2021

 

Conclusion

Dr. Shahar Shelly exemplifies excellence in clinical practice, academic leadership, and innovative research. His focus on using cutting-edge technologies like AI and biomarker discovery aims to transform the diagnosis and treatment of complex neurological and neuromuscular disorders. Driven by a commitment to precision medicine, his career reflects a blend of academic rigor, clinical expertise, and groundbreaking contributions that continue to shape the future of neurology.